Biotech platform investing

A pancreatic pill proves pan-RAS is druggable. Lung and colon will price the claim

Rasonque roughly doubled median survival against a 6.7-month chemotherapy arm in a cancer where nearly every tumor carries a KRAS mutation. Neither condition repeats in the bigger indications.